TNFRSF11A and arthritic joint disease: Receptor activator of nuclear factor κB ligand (RANKL), and its receptor, RANK, have been found to be key factors in the stimulation of osteoclast formation, and they have also been suggested to play major roles in inflammation-induced bone loss and joint destruction in arthritis [1,2].